1. Home
  2. RYTM vs BOX Comparison

RYTM vs BOX Comparison

Compare RYTM & BOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • BOX
  • Stock Information
  • Founded
  • RYTM 2008
  • BOX 2005
  • Country
  • RYTM United States
  • BOX United States
  • Employees
  • RYTM N/A
  • BOX N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • BOX Computer Software: Prepackaged Software
  • Sector
  • RYTM Health Care
  • BOX Technology
  • Exchange
  • RYTM Nasdaq
  • BOX Nasdaq
  • Market Cap
  • RYTM 3.8B
  • BOX 4.4B
  • IPO Year
  • RYTM 2017
  • BOX 2015
  • Fundamental
  • Price
  • RYTM $57.38
  • BOX $31.42
  • Analyst Decision
  • RYTM Strong Buy
  • BOX Strong Buy
  • Analyst Count
  • RYTM 12
  • BOX 10
  • Target Price
  • RYTM $75.42
  • BOX $35.10
  • AVG Volume (30 Days)
  • RYTM 671.0K
  • BOX 1.2M
  • Earning Date
  • RYTM 05-07-2025
  • BOX 05-27-2025
  • Dividend Yield
  • RYTM N/A
  • BOX N/A
  • EPS Growth
  • RYTM N/A
  • BOX 102.98
  • EPS
  • RYTM N/A
  • BOX 1.36
  • Revenue
  • RYTM $136,863,000.00
  • BOX $1,090,130,000.00
  • Revenue This Year
  • RYTM $43.84
  • BOX $7.14
  • Revenue Next Year
  • RYTM $65.62
  • BOX $7.11
  • P/E Ratio
  • RYTM N/A
  • BOX $23.12
  • Revenue Growth
  • RYTM 48.88
  • BOX 5.05
  • 52 Week Low
  • RYTM $35.17
  • BOX $24.63
  • 52 Week High
  • RYTM $68.58
  • BOX $35.74
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 43.00
  • BOX 56.86
  • Support Level
  • RYTM $62.69
  • BOX $30.71
  • Resistance Level
  • RYTM $65.53
  • BOX $31.49
  • Average True Range (ATR)
  • RYTM 3.04
  • BOX 0.54
  • MACD
  • RYTM -0.73
  • BOX 0.13
  • Stochastic Oscillator
  • RYTM 1.14
  • BOX 86.90

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About BOX Box Inc.

Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file-sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature to enhance workflow management and collaboration.

Share on Social Networks: